HOME
医局紹介
外来・病棟のご案内
研究室紹介
病診連携について
入局案内
入局案内
HOME > 医局紹介 > 業績一覧 > 2019年
医局紹介

業績一覧

2019年

  1. Kanaya T, Noguchi T, Otsuka F, Asaumi Y, Kataoka Y, Morita Y, Miura H, Nakao K, Fujino M, Kawasaki T, Nishimura K, Inoue T, Narula J, Yasuda S. Optical coherence tomography-verified morphological correlates of high-intensity coronary plaques on non-contrast T1-weighted magnetic resonance imaging in patients with stable coronary artery disease. Eur Heart J Cardiovasc Imaging 2019; 20: 75-83
  2. Tanaka A, Kawaguchi A, Oyama J, Ishizu T, Ito H, Fukui J, Kondo T, Kuroki S, Nanasato M, Higashi Y, Kaku K, Inoue T, Murohara T, Node K. Differential effect of concomitant antidiabetic agents on carotid atherosclerosis: a subgroup analysis of the PROLOGUE study. Heart Vessels 2019; 34: 375-384
  3. Watanabe R, Amano H, Saito F, Toyoda S, Sakuma M, Abe S, Nakajima T, Inoue T. Echocardiographic surrogates of right atrial pressure in pulmonary hypertension. Heart Vessels 2019; 34:477-483
  4. Maruyama H, Miyata K, Mikame M, Taguchi A, Guili C, Shimura M, Murayama K, Inoue T, Yamamoto S, Sugimura K, Tamita K, Kawasaki T, Kajihara J, Onishi A, Sugiyama H, Sakai T, Murata I, Oda T, Toyoda S, Hanawa K, Fujimura T, Ura S, Matsumura M, Takano H, Yamashita S, Matsukura G, Tazawa R, Shiga T, Ebato M, Satoh H, Ishii S. Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis. Genet Med. 2019; 21: 44-52
  5. Maruyama H, Miyata K, Mikame M, Taguchi A, Guili C, Shimura M, Murayama K, Inoue T, Yamamoto S, Sugimura K, Tamita K, Kawasaki T, Kajihara J, Onishi A, Sugiyama H, Sakai T, Murata I, Oda T, Toyoda S, Hanawa K, Fujimura T, Ura S, Matsumura M, Takano H, Yamashita S, Matsukura G, Tazawa R, Shiga T, Ebato M, Satoh H, Ishii S. Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis. Genet Med. 2019; 21: 512-515
  6. Nakamura K, Naito S, Sasaki T, Take Y, Minami K, Kitagawa Y, Motoda H, Inoue M, Otsuka Y, Niijima K, Yamashita E, Sugai Y, Kumagai K, Koyama K, Funabashi N, Oshima S. Uninterrupted vs. interrupted periprocedural direct oral anticoagulants for catheter ablation of atrial fibrillation: a prospective randomized single-centre study on post-ablation thrombo-embolic and haemorrhagic events. Europace 2019; 21: 259-267
  7. Takano N, Amiya E, Oguri G, Nakayama A, Taya M, Nakajima T, Morita H, Komuro I. Influence of atrial fibrillation on oxygen uptake and exercise tolerance in cardiovascular patients; close association with heart rate response. Int J Cardiol Heart Vasc 2019; 22: 84-91
  8. Okura H, Saito Y, Soeda T, Nakao K, Ozaki Y, Kimura K, Ako J, Noguchi T, Yasuda S, Suwa S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Hirohata A, Morita Y, Inoue T, Okamura A, Uematsu M, Hirata K, Tanabe K, Shibata Y, Owa M, Tsujita K, Nishimura K, Miyamoto Y, Ishihara M; J-MINUET investigators. Frequency and prognostic impact of intravascular imaging-guided urgent percutaneous coronary intervention in patients with acute myocardial infarction: results from J-MINUET. Heart Vessels 2019; 34: 564-571
  9. Abe S, Nishino S, Sakuma M, Inoue T. Low endothelial sheer stress -a silent killer. Circ J 2019; 83: 1197-1199
  10. Kajikawa M, Maruhashi T, Kishimoto S, Matsui S, Hashimoto H, Takaeko,Y, Mohamad YF, Kihara Y, Chayama K, Goto C, Noma K, Nakashima A, Tomiyama H, Takase B, Kohro T, Suzuki T, Ishizu T, Ueda S, Yamazaki T, Furumoto T, Kario K, Inoue T, Koba S, Watanabe K, Takemoto Y, Hano T, Sata M, Ishibashi Y, Node K, Maemura K, Ohya Y, Furukawa T, Ito H, Ikeda H, Yamashina A, Higashi Y. Target of triglycerides as residual risk for cardiovascular events in patients with coronary artery disease: post hoc analysis of the FMD-J Study A. Circ J 2019; 83: 1064-1071
  11. Okuno T, Aoki J, Tanabe K, Nakao K, Ozaki Y, Kimura K, Ako J, Noguchi T, Yasuda S, Suwa S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Okamura A, Mano T, Hirata K, Shibata Y, Owa M, Tsujita K, Funayama H, Kokubu N, Kozuma K, Uemura S, Tobaru T, Saku K, Oshima S, Nishimura K, Miyamoto Y, Ogawa H, Ishihara M. Admission heart rate is a determinant of effectiveness of beta-blockers in acute myocardial infarction patients. Circ J 2019; 83: 1054-1063
  12. Toyoda S, Arikawa T, Inami S, Nishikawa R, Saito F, Watanabe R, Sakuma M, Kanaya T, Abe S, Inoue T. Patients with congestive heart failure benefit for long-term treatment effects with novel treatment using azosemide compared with furosemide derived from existing retrospective study data -CONTENTED -. J Cardiovasc Pharmacol 2019; 73: 365-372
  13. Abe S, Inoue T. Perspectives of a catheter-based nitric oxide sensor for the evaluation of endothelial function. Vasc Fail 2019; 3: 1-5
  14. Arikawa T, Masuyama D, Waku R, Hirose S, Suwa H, Haruyama A, Inami S, Sakuma M, Toyoda S, Abe S, Nakajima T, Inoue T. Obstructive sleep apnea as a risk factor for the onset and progression of aortic dissection. Vasc Fail 2019; 3: 6-11
  15. Koyabu Y, Abe S, Sakuma M, Kanaya T, Obi S, Yoneda S, Toyoda S, Nakajima T, Inoue T. Short-term safety and mid-term efficacy of prasugrel versus clopidogrel in patients undergoing percutaneous coronary intervention. Intern Med 2019; 58: 2315-2322
  16. Saito F, Toyoda S, Arikawa T, Inami S, Watanabe R, Obi S, Sakuma M, Kanaya T, Abe S, Nakajima T, Inoue T. Prediction of acute phase complications in patients with infectious endocarditis. Intern Med 2019; 58: 2323-2331
  17. Inoue K, Kishimoto S, Akimoto K, Sakuma M, Toyoda S, Inoue T, Yoshida K, Shimoda M, Suzuki S. Cancer-associated fibroblasts show heterogeneous gene expression and induce vascular endothelial growth factor A (VEGFA) in response to environmental stimuli. Ann Gastroenterol Surg 2019; 3: 416-425
  18. Nishino S, Sakuma M, Kanaya T, Nasuno T, Tokura M, Toyoda S, Abe S, Nakamura D, Tanaka K, Attizzani G, Bezerra HG, Costa MA, Inoue T. Neointimal tissue characterization after implantation of drug-eluting stents by optical coherence tomography: quantitative analysis of optical density. Int J Cardiovasc Imaging 2019; 35: 1971-1978
  19. Tanaka A, Shimabukuro M, Machii N, Teragawa H, Okada Y, Shima KR, Takamura T, Taguchi I, Hisauchi I, Toyoda S, Matsuzawa Y, Tomiyama H, Yamaoka-Tojo M, Yoshida H, Sato Y, Ikehara Y, Ueda S, Higashi Y, Node K, on behalf of the EMBLEM Investigators. Effect of empagliflozin on endothelial function in patients with type 2 diabetes and cardiovascular diseases: results from the multicenter, randomized, placebo controlled, double-blind EMBLEM trial. Diabetes Care 2019; 42: e159-e161
  20. Yasu T, Shimoyama M, Wada H, Iwakura T, Toyoda S, Kawabe A, Sugiyama T. Homozygous familial hypercholesterolemia with stenosis of the left anterior descending coronary artery successfully treated with weekly low-density lipoprotein apheresis for 16 years without percutaneous coronary intervention. Clin Case Rep. 2019;7: 1608-1611
  21. Tajima E, Sakuma M, Tokoi S, Matsumoto T, Saito F, Toyoda S, Abe S, Inoue T. The comparison of endothelial function between conduit artery and microvasculature in patients with coronary artery disease. Cardiol J (in press)
  22. Sakuma M, Toyoda S, Inoue T, Node K. Inflammation in pulmonary artery hypertension. Vascul Pharmacol (in press)
  23. Okuno T, Aoki J, Tanabe K, Nakao K, Ozaki Y, Kimura K, Ako J, Noguchi T, Yasuda S, Suwa S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Okamura A, Mano T, Hirata K, Shibata Y, Owa M, Tsujita K, Funayama H, Kokubu N, Kozuma K, Uemura S, Tobaru T, Saku K, Ohshima S, Nishimura K, Miyamoto Y, Ogawa H, Ishihara M; J-MINUET investigators. Association of onset-season with characteristics and long-term outcomes in acute myocardial infarction patients: results from the Japanese registry of acute myocardial infarction diagnosed by universal definition (J-MINUET) substudy. Heart Vessels (in press)
  24. Sakuma M, Toyoda S, Hashimoto R, Yazawa H, Masuyama T, Hirose S, Waku R, Hasumi H, Numao T, Abe S, Inoue T. Add-on ezetimibe treatment to low-dose statins vs medium-intensity statin monotherapy in coronary artery disease patients with poorly controlled dyslipidemia. Hypertens Res (in press)
  25. Toyoda S, Haruyama A, Inami S, Arikawa T, Saito F, Watanabe R, Sakuma M, Abe S, Nakajima T, Tanaka A, Node K, Inoue T. Effects of carvedilol vs bisoprolol on inflammation and oxidative stress in patients with chronic heart failure. J Cardiol (in press)
  26. Toyoda S, Saito F, Inoue T. How to construct a novel criteria to predict complications with infectious endocarditis. Intern Med (in press)
  27. Ishizuka H, Uematsu A, Mizushima Y, Nozawa N, Katayanagi S, Matsumoto K, Nishikawa K, Takahashi R, Arakawa T, Sawagichi T, Yasuda T, Yamaguchi S, Ogawa H, Shibasaki I, Toyoda S, Hortobagyi T, Fukuda H, Inoue T, Mizushima T, Nakajima T. Blood flow restriction increases the neural activation of the knee extensors during very low-intensity leg extension exercise in cardiovascular patients: a pilot study. J Clin Med (in press)
  28. Nakajima T, Shibasaki I, Sawaguchi T, Haruyama A, Kaneda H, Nakajima T, Hasegawa T, Arikawa T, Obi S, Sakuma M, Ogawa H, Toyoda S, Nakamura F, Abe S, Fukuda H, Inoue T. Growth differentiation factor-15 (GDF-15) is a biomarker of muscle wasting and renal dysfunction in preoperative cardiovascular surgery patients. J Clin Med (in press)
  29. Sawaguchi T, Nakajima T, Haruyama A, Hasegawa T, Shibasaki I, Nakajima Ta, Kaneda H, Arikawa T, Obi S, Sakuma M, Ogawa H, Takei Y, Toyoda S, Nakamura F Abe S, Fukuda H, Inoue T. Association of serum leptin and adiponectin concentrations with echocardiographic parameters and pathophysiological states in patients with cardiovascular disease receiving cardiovascular surgery. PLoS One (in press)
ページトップ